As 2025 winds down, brokers favor ZUMZ, BODI, CVI, CIVI, and ADNT. These stocks show earnings strength and valuation appeal.
Adient (ADNT) reported earnings 30 days ago. What's next for the stock?
ADNT posts higher Q4 sales but misses EPS forecasts as segment margins narrow and FY26 outlook points to lower revenues and EBITDA.
Adient plc ( ADNT ) Q4 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Linda Conrad Jerome Dorlack - President, CEO & Director Mark Oswald - Executive VP & CFO Conference Call Participants Colin Langan - Wells Fargo Securities, LLC, Research Division Emmanuel Rosner - Wolfe Research, LLC Dan Levy - Barclays Bank PLC, Research Division Nathan Jones - Stifel, Nicolaus & Company, Incorporated, Research Division Joseph Spak - UBS Investment Bank, Research Division Presentation Operator Welcome to the Adient's Fourth Quarter and Full Year 2025 Earnings Call. [Operator Instructions] I'd like to inform all participants that today's call is being recorded.
While the top- and bottom-line numbers for Adient (ADNT) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Adient (ADNT) came out with quarterly earnings of $0.52 per share, missing the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.68 per share a year ago.
Adient (ADNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ADNT's fiscal Q3 EPS misses estimates despite Y/Y growth, while sales beat forecasts, and the full-year revenue outlook has been raised.
While the top- and bottom-line numbers for Adient (ADNT) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.